The committee discussed the following topics: (1) approaches to evaluate the effect of renal impairment on drug exposure, and (2) best practice considerations for translating pharmacokinetic (PK) information into dose individualization instructions.
Back to All Events
Earlier Event: April 26
Antimicrobial Drugs Advisory Committee
Later Event: May 8
Pulmonary-Allergy Drugs Advisory Committee